Ontruzant 150 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQV6Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $78,467
Award facts
- Contract value 100% obligated
- $78,467.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $78,467.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 150 mg vials of Ontruzant, a trastuzumab biosimilar used in oncology treatment. Issued on January 29, 2026, this non-competitive delivery order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, with completion scheduled for January 30, 2026. This award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, leverages its extensive federal contract portfolio with DLA to supply critical medications across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs. The delivery order for Ontruzant reflects the company's capability to efficiently fulfill specialized oncology pharmaceutical requirements for the Department of Defense's medical supply chain on a firm fixed-price basis without set-aside restrictions, demonstrating its competitive standing among federal pharmaceutical vendors.
Quick answers
Who was awarded contract SPE2DR26FQV6Q?
SPE2DR26FQV6Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FQV6Q worth?
The government has obligated $78,467 on SPE2DR26FQV6Q.
Is contract SPE2DR26FQV6Q an order under another contract?
Yes. SPE2DR26FQV6Q is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV6Q competed?
The extent of competition for SPE2DR26FQV6Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award